RASSF1A and the rs2073498 cancer associated SNP

Frontiers in Oncology

Volumn 1, Issue DEC, 2011, Pages

  Donninger, Howard ^a   Barnoud, Thibaut ^a   Nelson, Nick ^a   Kassler, Suzanna ^a   Clark, Jennifer ^a   Cummins, Timothy D ^b   Powell, David W ^b   Nyante, Sarah ^c   Millikan, Robert C ^c   Clark, Geoffrey J ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Breast cancer; Ras; RASSF1A; SNP

Indexed keywords

EID: 84885744050     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2011.00054     Document Type: Article

References (54)

1. Adam, P. J., Boyd, R., Tyson, K. L., Fletcher, G. C., Stamps, A., Hudson, L., Poyser, H. R., Redpath, N., Griffiths, M., Steers, G., Harris, A. L., Patel, S., Berry, J., Loader, J. A., Townsend, R. R., Daviet, L., Legrain, P., Parekh, R., and Terrett, J. A. (2003). Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J. Biol. Chem. 278, 6482-6489.
2. Avruch, J., Praskova, M., Ortiz-Vega, S., Liu, M., and Zhang, X. F. (2006). Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases. Methods Enzymol. 407, 290-310.
3. Baksh, S., Tommasi, S., Fenton, S., Yu, V. C., Martins, L. M., Pfeifer, G. P., Latif, F., Downward, J., and Neel, B. G. (2005). The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. Mol. Cell 18, 637-650.
4. Bergqvist, J., Latif, A., Roberts, S. A., Hadfield, K. D., Lalloo, F., Howell, A., Evans, D. G., and Newman, W. G. (2010). RASSF1A polymorphism in familial breast cancer. Fam. Cancer 9, 263-265.
5. Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Conner, E. A., Lee, J. S., Factor, V. M., and Thorgeirsson, S. S. (2006). Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 130, 1117-1128.
6. Chien, C. L., Lu, K. S., Lin, Y. S., Hsieh, C. J., and Hirokawa, N. (2005). The functional cooperation of MAP1A heavy chain and light chain 2 in the binding of microtubules. Exp. Cell Res. 308, 446-458.
7. Claperon, A., and Therrien, M. (2007). KSR and CNK: two scaffolds regulating RAS-mediated RAF activation. Oncogene 26, 3143-3158.
8. Cummins, T. D., Barati, M. T., Coventry, S. C., Salyer, S. A., Klein, J. B., and Powell, D. W. (2010). Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-beta signaling. Biochim. Biophys. Acta 1804, 653-661.
9. Dallol, A., Agathanggelou, A., Fenton, S. L., hmed-Choudhury, J., Hesson, L., Vos, M. D., Clark, G. J., Downward, J., Maher, E. R., and Latif, F. (2004). RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res. 64, 4112-4116.
10. Dammann, R., Li, C., Yoon, J. H., Chin, P. L., Bates, S., and Pfeifer, G. P. (2000). Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet. 25, 315-319.
11. Dammann, R., Schagdarsurengin, U., Seidel, C., Strunnikova, M., Rastetter, M., Baier, K., and Pfeifer, G. P. (2005). The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol. Histopathol. 20, 645-663.
12. Donninger, H., Allen, N., Henson, A., Pogue, J., Williams, A., Gordon, L., Kassler, S., Dunwell, T., Latif, F., and Clark, G. J. (2011). Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions. J. Biol. Chem. 286, 18483-18491.
13. Donninger, H., Vos, M. D., and Clark, G. J. (2007). The RASSF1A tumor suppressor. J. Cell Sci. 120, 3163-3172.
14. Drugan, J. K., Khosravi-Far, R., White, M. A., Der, C. J., Sung, Y. J., Hwang, Y. W., and Campbell, S. L. (1996). Ras interaction with two distinct binding domains in Raf-1 may be required for Ras transformation. J. Biol. Chem. 271, 233-237.
15. El-Kalla, M., Onyskiw, C., and Baksh, S. (2010). Functional importance of RASSF1A microtubule localization and polymorphisms. Oncogene 29, 5729-5740.
16. Fiordalisi, J. J., Johnson, R. L., Ulku, A. S., Der, C. J., and Cox, A. D. (2001). Mammalian expression vectors for Ras family proteins: generation and use of expression constructs to analyze Ras family function. Methods Enzymol. 332, 3-36.
17. Gao, B., Xie, X. J., Huang, C., Shames, D. S., Chen, T. T., Lewis, C. M., Bian, A., Zhang, B., Olopade, O. I., Garber, J. E., Euhus, D. M., Tomlinson, G. E., and Minna, J. D. (2008). RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res. 68, 22-25.
18. Gunzel, D., Stuiver, M., Kausalya, P. J., Haisch, L., Krug, S. M., Rosenthal, R., Meij, I. C., Hunziker, W., Fromm, M., and Müller, D. (2009). Claudin-10 exists in six alternatively spliced isoforms that exhibit distinct localization and function. J. Cell Sci. 122, 1507-1517.
19. Guo, C., Tommasi, S., Liu, L., Yee, J. K., Dammann, R., and Pfeifer, G. P. (2007). RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr. Biol. 17, 700-705.
20. Hamilton, G., Yee, K. S., Scrace, S., and O'neill, E. (2009). ATM regulates a RASSF1A-dependent DNA damage response. Curr. Biol. 19, 2020-2025.
21. Harvey, K., and Tapon, N. (2007). The Salvador-Warts-Hippo pathway-an emerging tumour-suppressor network. Nat. Rev. Cancer 7, 182-191.
22. Humphries, M. J. (2001). Cell-substrate adhesion assays. Curr. Protoc. Cell Biol. 9, 9.1.
23. Ip, Y. C., Cheung, S. T., Lee, Y. T., Ho, J. C., and Fan, S. T. (2007). Inhibition of hepatocellular carcinoma invasion by suppression of claudin-10 in HLE cells. Mol. Cancer Ther. 6, 2858-2867.
24. Ivaska, J., Pallari, H. M., Nevo, J., and Eriksson, J. E. (2007). Novel functions of vimentin in cell adhesion, migration, and signaling. Exp. Cell Res. 313, 2050-2062.
25. Jacquemart, I. C., Springs, A. E., and Chen, W. Y. (2009). Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice. Int. J. Oncol. 34, 517-528.
26. Kanzaki, H., Hanafusa, H., Yamamoto, H., Yasuda, Y., Imai, K., Yano, M., Aoe, M., Shimizu, N., Nakachi, K., Ouchida, M., and Shimizu, K. (2006). Single nucleotide polymorphism at codon 133 of the RASSF1 gene is preferentially associated with human lung adenocarcinoma risk. Cancer Lett. 238, 128-134.
27. Kenny, H. A., Kaur, S., Coussens, L. M., and Lengyel, E. (2008). The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J. Clin. Invest. 118, 1367-1379.
28. King, E. R., Tung, C. S., Tsang, Y. T., Zu, Z., Lok, G. T., Deavers, M. T., Malpica, A., Wolf, J. K., Lu, K. H., Birrer, M. J., Mok, S. C., Gershenson, D. M., and Wong, K. K. (2011). The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer. Am. J. Surg. Pathol. 35, 904-912.
29. Liu, L., Baier, K., Dammann, R., and Pfeifer, G. P. (2007). The tumor suppressor RASSF1A does not interact with Cdc20, an activator of the anaphase-promoting complex. Cell Cycle 6, 1663-1665.
30. Liu, L., Tommasi, S., Lee, D. H., Dammann, R., and Pfeifer, G. P. (2003). Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 22, 8125-8136.
31. Matallanas, D., Romano, D., Yee, K., Meissl, K., Kucerova, L., Piazzolla, D., Baccarini, M., Vass, J. K., Kolch, W., and O'neill, E. (2007). RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol. Cell 27, 962-975.
32. McAfee, K. J., Duncan, D. T., Assink, M., and Link, A. J. (2006). Analyzing proteomes and protein function using graphical comparative analysis of tandem mass spectrometry results. Mol. Cell. Proteomics 5, 1497-1513.
33. Ness, R. B., Grisso, J. A., Klapper, J., and Vergona, R. (2000). Racial differences in ovarian cancer risk. J. Natl. Med. Assoc. 92, 176-182.
34. Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003). A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658.
35. Nyante, S. J., Gammon, M. D., Kaufman, J. S., Bensen, J. T., Lin, D. Y., Barnholtz-Sloan, J. S., Hu, Y., He, Q., Luo, J., and Millikan, R. C. (2011). Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes. Breast Cancer Res. Treat. 129, 593-606.
36. Powell, D. W., Weaver, C. M., Jennings, J. L., McAfee, K. J., He, Y., Weil, P. A., and Link, A. J. (2004). Cluster analysis of mass spectrometry data reveals a novel component of SAGA. Mol. Cell Biol. 24, 7249-7259.
37. Praskova, M., Khoklatchev, A., Ortiz-Vega, S., and Avruch, J. (2004). Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem. J. 381, 453-462.
38. Rabizadeh, S., Xavier, R. J., Ishiguro, K., Bernabeortiz, J., Lopez-Ilasaca, M., Khokhlatchev, A., Mollahan, P., Pfeifer, G. P., Avruch, J., and Seed, B. (2004). The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death. J. Biol. Chem. 2.79, 29247-29254.
39. Reeves, M. E., Baldwin, S. W., Baldwin, M. L., Chen, S. T., Moretz, J. M., Aragon, R. J., Li, X., Strong, D. D., Mohan, S., and Amaar, Y. G. (2010). Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis. BMC Cancer 10, 562. doi:10.1186/1471-2407-10-562
40. Richter, A. M., Pfeifer, G. P., and Dammann, R. H. (2009). The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim. Biophys. Acta 1796, 114-128.
41. Satelli, A., and Li, S. (2011). Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell. Mol. Life Sci. 68, 3033-3046.
42. Schagdarsurengin, U., Seidel, C., Ulbrich, E. J., Kolbl, H., Dittmer, J., and Dammann, R. A. (2005). Polymorphism at codon 133 of the tumor suppressor RASSF1A is associated with tumorous alteration of the breast. Int. J. Oncol. 27, 185-191.
43. Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L., Smigielski, E. M., and Sirotkin, K. (2001). dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308-311.
44. Shivakumar, L., Minna, J., Sakamaki, T., Pestell, R., and White, M. A. (2002). The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell Biol. 22, 4309-4318.
45. Song, M. S., and Lim, D. S. (2004). Control of APC-Cdc20 by the tumor suppressor RASSF1A. Cell Cycle 3, 574-576.
46. Song, M. S., Song, S. J., Kim, S. Y., Oh, H. J., and Lim, D. S. (2008). The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex. EMBO J. 27, 1863-1874.
47. Tan, K. O., Fu, N. Y., Sukumaran, S. K., Chan, S. L., Kang, J. H., Poon, K. L., Chen, B. S., and Yu, V. C. (2005). MAP-1 is a mitochondrial effector of Bax. Proc. Natl. Acad. Sci. U.S.A. 102, 14623-14628.
48. Tommasi, S., Besaratinia, A., Wilczynski, S. P., and Pfeifer, G. P. (2011). Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy. Oncogene 30, 690-700.
49. Tommasi, S., Dammann, R., Jin, S. G., Zhang, X. X., Avruch, J., and Pfeifer, G. P. (2002). RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Oncogene 21, 2713-2720.
50. Tsujii, M., and DuBois, R. N. (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493-501.
51. van der, W. L., and Adams, D. J. (2007). The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim. Biophys. Acta 1776, 58-85.
52. Vos, M. D., and Clark, G. J. (2005). RASSF family proteins and Ras transformation. Methods Enzymol. 407, 311-322.
53. Vos, M. D., Dallol, A., Eckfeld, K., Allen, N. P., Donninger, H., Hesson, L. B., Calvisi, D., Latif, F., and Clark, G. J. (2006). The RASSF1A tumor suppressor activates Bax via MOAP-1. J. Biol. Chem. 281, 4557-4563.
54. Vos, M. D., Martinez, A., Elam, C., Dallol, A., Taylor, B. J., Latif, F., and Clark, G. J. (2004). A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res. 64, 4244-4250.